Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature

Curr Pharm Des. 2022;28(21):1695-1702. doi: 10.2174/1381612828666220418132847.

Abstract

Vitamin D is an important immune-modulator with anti-inflammatory properties. While this prohormone has been studied extensively in the prevention and treatment of COVID-19, findings have been inconsistent regarding its overall benefit in patients hospitalized with COVID-19. Most studies to date have been observational in nature, not accounting for the use of corticosteroids. Furthermore, the few randomized clinical trials designed to examine the effect of vitamin D supplementation on COVID-19 outcomes have been relatively small and thus insufficiently powered to assure a balance of corticosteroid use between study arms. The current perspective addresses the interaction of vitamin D and corticosteroids as a potential explanation for the divergent results reported in the literature. Future research on vitamin D and COVID-19 will benefit by considering this interaction, especially among hospitalized patients requiring oxygen and mechanical ventilation.

Keywords: Anti-inflammatory; COVID-19; SARS-CoV-2; corticosteroids; cytokine storm; vitamin D.

Publication types

  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2
  • Vitamin D / therapeutic use
  • Vitamins

Substances

  • Adrenal Cortex Hormones
  • Vitamins
  • Vitamin D